Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Hematology"
DOI: 10.1002/ajh.26466
Abstract: Castleman disease (CD) is a rare lymphoproliferative disease characterized by diverse clinical and pathologic features. Due to its rarity, there are limited studies comparing currently available therapies. The role of autologous stem cell transplantation (ASCT)… read more here.
Keywords: stem cell; disease; castleman disease; transplantation ... See more keywords
Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the EBMT
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5039
Abstract: Achieving complete remission (CR) is the main goal in AML treatment and a prerequisite for successful autologous stem cell transplantation (ACT). read more here.
Keywords: complete remission; autologous stem; stem cell; cell transplantation ... See more keywords
Single or tandem autologous stem cell transplantation for treating Chinese patients with refractory/relapsed classical Hodgkin lymphoma
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5765
Abstract: Autologous stem cell transplantation (ASCT) is the standard treatment strategy for refractory or relapsed classical Hodgkin lymphoma (R/R cHL). However, a single transplantation is insufficient to cure the disease because of unfavorable risk factors. Herein,… read more here.
Keywords: refractory relapsed; relapsed classical; stem cell; cell transplantation ... See more keywords
Tandem Versus Single Autologous Stem Cell Transplantation for High‐Risk Multiple Myeloma in the Era of Novel Agents: A Real‐World Study of China
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Medicine"
DOI: 10.1002/cam4.70573
Abstract: This study compares the efficacy and safety of single autologous stem cell transplantation (ASCT) versus tandem ASCT for multiple myeloma (MM) patients in the era of novel agents. read more here.
Keywords: multiple myeloma; cell transplantation; era novel; stem cell ... See more keywords
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: a Fondazione Italiana Linfomi real-life experience.
Sign Up to like & getrecommendations! Published in 2021 at "Hematological oncology"
DOI: 10.1002/hon.2939
Abstract: The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous stem cell transplantation (ASCT). This strategy allows almost 50% of patients to be cured. Post-ASCT maintenance treatment with… read more here.
Keywords: hodgkin lymphoma; cell transplantation; stem cell; post ... See more keywords
COVID-19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantation.
Sign Up to like & getrecommendations! Published in 2023 at "Hematological oncology"
DOI: 10.1002/hon.3127
Abstract: Here we report two cases of myeloma patients who became positive for SARS-CoV-2 infection during the acute phase of autologous stem cell transplant. Both patients were promptly treated with monoclonal antibodies and remdesivir, and, despite… read more here.
Keywords: myeloma patients; autologous stem; covid impact; stem cell ... See more keywords
Optimizing autologous stem cell collections for patients with multiple myeloma receiving G‐CSF and Plerixafor: A single center project
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Apheresis"
DOI: 10.1002/jca.22127
Abstract: Increasing indications for cellular therapy collections have stressed our healthcare system, with autologous collections having a longer than desired wait time until apheresis collection. This quality improvement initiative was undertaken to accommodate more patients within… read more here.
Keywords: stem cell; autologous stem; collections patients; patients multiple ... See more keywords
[Spontaneous remission of HCV infection after autologous stem cell transplantation in a 58-year-old man].
Sign Up to like & getrecommendations! Published in 2017 at "Der Internist"
DOI: 10.1007/s00108-017-0206-3
Abstract: We report about a 58-year-old man with a chronic and treatment-naive hepatitis C virus (HCV) infection of genotype 1b, who had undergone autologous stem cell transplantation twice due to multiple myeloma. Subsequently, a high-level viremic reactivation of an occult… read more here.
Keywords: old man; infection; hcv infection; year old ... See more keywords
Autologous stem cell transplantation from 2011 to 2022 in Japanese patients aged ≥ 65 years with relapsed or refractory diffuse large B-cell lymphoma
Sign Up to like & getrecommendations! Published in 2025 at "Annals of Hematology"
DOI: 10.1007/s00277-025-06519-3
Abstract: High-dose chemotherapy with autologous stem cell transplantation (ASCT) is an option for patients aged ≥ 65 years with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL). Few data are available to select patients suitable for chimeric… read more here.
Keywords: cell; autologous stem; patients aged; aged years ... See more keywords
Prehabilitation to improve function after autologous stem cell transplantation: A pilot randomized controlled trial (PIRATE)
Sign Up to like & getrecommendations! Published in 2025 at "Supportive Care in Cancer"
DOI: 10.1007/s00520-025-09179-1
Abstract: Exercise and nutrition interventions are not part of routine care for those undergoing autologous stem cell transplant (autoSCT). We aimed to explore estimates of effect, safety and feasibility of multidisciplinary prehabilitation for improving physical capacity… read more here.
Keywords: stem cell; trial; autologous stem; pilot randomized ... See more keywords
A Review of Autologous Stem Cell Transplantation in Lymphoma
Sign Up to like & getrecommendations! Published in 2017 at "Current Hematologic Malignancy Reports"
DOI: 10.1007/s11899-017-0382-1
Abstract: Purpose of ReviewChemotherapy remains the first-line therapy for aggressive lymphomas. However, 20–30% of patients with non-Hodgkin lymphoma (NHL) and 15% with Hodgkin lymphoma (HL) recur after initial therapy. We want to explore the role of… read more here.
Keywords: lymphoma; stem cell; cell; autologous stem ... See more keywords